Real-time enrollment status for this generalized epilepsy clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:25 AM UTC
| NCT Number | NCT06425159 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Generalized Epilepsy |
| Phase | Clinical Trial |
| Target Enrollment | 242 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Biohaven Therapeutics Ltd. |
| Last Updated on CT.gov | January 20, 2026 (Jan 20, 2026) |
As of March 2, 2026: Clinical trial NCT06425159 is currently active_not_recruiting participants. This clinical trial study for generalized epilepsy is not currently accepting new participants at 46 locations across the United States. The study is sponsored by Biohaven Therapeutics Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06425159 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06425159 was last updated Jan 20, 2026 (January 20, 2026). HelloStudys verifies this status automatically.